anti- AHCY antibody

Este producto es parte de AHCY - Adenosylhomocysteinase (Like)
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- AHCY antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00227
tested applications
ELISA, IHC, IF, WB

Description

Adenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
Primary Antibodies
Immunogen Target
S-adenosylhomocysteine hydrolase
Host
Mouse
Reactivity
human
Recommended Dilution
WB: 1:500-1:5000; IHC: 1:20-1:200; IF: 1:10-1:100
Clonality
monoclonal
Conjugation
Unconjugated
Isotype
IgG2b
Clone ID
5F4
Observed MW
48 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Protein A+G purification
Size 1
100µg
Form
liquid
Tested Applications
ELISA, IHC, IF, WB
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P23526
Gene ID
191
Alias
SAHH,adoHcyase
Background
Antibody anti-AHCY
Status
RUO
Note
This product is for research use only.

Descripción

AHCY, also known as S-adenosylhomocysteine hydrolase, is a critical enzyme in the methionine cycle that catalyzes the reversible hydrolysis of S-adenosylhomocysteine (SAH) into homocysteine and adenosine. This reaction is essential for maintaining cellular methylation reactions, as SAH is a potent inhibitor of methyltransferases. AHCY is ubiquitously expressed and localized in the cytoplasm and nucleus, where it regulates methylation-dependent processes such as DNA and histone modification, gene expression, and cell signaling. Dysregulation of AHCY leads to the accumulation of SAH, disrupting methylation and contributing to diseases such as homocystinuria, cardiovascular disease, and neurodegenerative disorders. Mutations in the AHCY gene can cause autosomal recessive hypermethioninemia. AHCY is also being studied as a potential target in cancer and metabolic disorders due to its pivotal role in methylation homeostasis.

Related Products

EH1440

Human AHCY(Adenosylhomocysteinase) ELISA Kit

Ver Producto
EM0560

Mouse Ahcy(Adenosylhomocysteinase) ELISA Kit

Ver Producto
FNab00226

anti- AHCY antibody

Adenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine.

Ver Producto